Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202404
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.

<<
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 201702

Price of this issue :
USD 98

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

In early 2017, continual decreases were seen in the domestic quoted prices of VE, mainly because of reduced demand from feed industry and increased market supply.

Published on 28th February, 2017

Affected by raw material supply, environmental protection policies and sales of chromium powder, China's market price of VK3 rebounded in March 2016 and has kept running high since. This upward trend is expected to go on over the coming period.

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

In Dec. 2016, the export volume of VE from China declined, due to reduced overseas demand and tightened supply as well as raised export price.

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

Published on 28th February, 2017

In Q4 2016, the domestic VC price kept surging affected by the restrained production and tightened supply. For these reasons, the export price of VC rose in Dec., while the corresponding export volume fell.

Published on 28th February, 2017

In late Jan. 2017, CSPC Pharmaceutical cooperated with Abbott China on marketing for the latter's adult nutrition brand Ensure CompleteTM, with the aim of expanding its shares in the healthcare market. As a domestic leading VC producer, CSPC Pharmaceutical has so far launched a series of VC healthcare products.

Published on 28th February, 2017

In Feb. 2017, Biostime completed 100% acquisition of Australia healthcare brand Swisse, following its purchase of an 83% stake in Sept. 2015. In light of increased sales of Swisse and decreased profits from IMF products, Biostime expects that this transaction can maximise Swisse's contribution to its future consolidated financial statement.

Published on 28th February, 2017

The Chinese VD3 market stayed depressed in the year 2016. Despite this, Garden Biochemical still recorded relatively high profitability, mainly thanks to its complete VD3 supply chain.

Published on 28th February, 2017

Recent years have seen many pharmaceutical enterprises extending their business to the FMCG (fast moving consumer goods) and healthcare markets, as pharmaceutical manufacturing have showed decreasing profits and drugs innovation has consumed increasing time and money. Yet, potential as the new markets are, few pharmaceutical enterprises have profited significantly given the intense competition.

Published on 28th February, 2017

In 2016, the export volume of healthcare pharmaceuticals decreased, indicating the pharmaceutical exports transitioned a slow growth period. Besides, there were new features in the trading. For example, exports of vitamins became higher concentrated.

Published on 28th February, 2017

In Feb. 2017, the CFDA released the Instructions for Healthcare Product Documentation (draft), specifying details of the healthcare product documentation system. Particularly, this draft emphasises the implementation of "one license for one brand", which is expected to curb illegal OBMs in vitamin healthcare business.

Published on 28th February, 2017


CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement